Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » ArcherDX, Bayer Partner on NGS-Based Companion Diagnostic Test Development

ArcherDX, Bayer Partner on NGS-Based Companion Diagnostic Test Development

May 14, 2020
|
staff reporter

NEW YORK ─ Life sciences firm Bayer and genomic analysis company ArcherDX on Thursday announced a global collaboration for the development and commercialization of a next-generation sequencing-based companion diagnostic test for Bayer's Vitrakvi (larotrectinib), which targets cancers with fusions in neurotrophic receptor tyrosine kinase (NTRK) genes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Through a Picture

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

Lancet, NEJM Papers Now Retracted

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Research Theft Bill to Be Proposed

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

Science Studies Examine Ancient Caribbean Islander Genomes, Barcoding to Track Food Contamination, More

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. CDC Develops Test for Simultaneous Detection of COVID-19, Flu

  2. Tumor Mutational Burden in Blood May Predict Immunotherapy Response in Head, Neck Cancer

  3. FDA Issues Emergency Use Authorization for University of Nebraska Medical Center Coronavirus Test

  4. Opti Medical Systems Gets CE Mark for Coronavirus Test Kit

  5. FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.